About Microchips Biotech
Microchips Biotech is a company based in Lexington (United States) founded in 1999 by David H Koch was acquired by Daré Bioscience in November 2019. Microchips Biotech has raised $118.61 million across 9 funding rounds from investors including Medtronic, Novartis and Teva Pharmaceuticals. The company has 10 employees as of December 31, 2022. Microchips Biotech operates in a competitive market with competitors including GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
- Headquarter Lexington, United States
- Employees 10 as on 31 Dec, 2022
- Founders David H Koch
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Microchips, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$118.61 M (USD)
in 9 rounds
-
Latest Funding Round
$18.65 M (USD), Series E
Jun 24, 2015
-
Investors
Medtronic
& 9 more
-
Employee Count
10
as on Dec 31, 2022
-
Acquired by
Daré Bioscience
(Nov 11, 2019)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Microchips Biotech
Microchips Biotech has successfully raised a total of $118.61M across 9 strategic funding rounds. The most recent funding activity was a Series E round of $18.65 million completed in June 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Microchips Biotech
Microchips Biotech has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include Medtronic, Novartis and Teva Pharmaceuticals.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
US focused venture capital firm
|
Locked | Locked | Locked | |
|
Early-stage tech startups are funded by Flybridge Capital Partners.
|
Locked | Locked | Locked | |
|
Early-stage life sciences and tech focused VC firm funding companies in the US
|
Locked | Locked | Locked |
Investor details for Microchips Biotech
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Microchips Biotech
Investment portfolio details for Microchips Biotech
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Microchips Biotech
Detailed financials for Microchips Biotech
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Microchips Biotech Comparisons
Peer comparison for Microchips Biotech
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Microchips Biotech
Microchips Biotech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| Locked | Locked | Locked |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| Locked | Locked | Locked |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| Locked | Locked | Locked |
Yeast cells are genetically engineered to produce medicinal products.
|
|
| Locked | Locked | Locked |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| Locked | Locked | Locked |
CRISPR-engineered cell and gene therapies are developed for research applications.
|
Detailed competitors of Microchips Biotech
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Microchips Biotech
Complete news archive for Microchips Biotech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Microchips Biotech
Microchips Biotech was founded in 1999 and raised its 1st funding round 3 years after it was founded.
Microchips Biotech is headquartered in Lexington, United States. It is registered at Lexington, Kentucky, United States.
Microchips Biotech is a funded company, having raised a total of $118.61M across 9 funding rounds to date.
As of Dec 31, 2022, the latest employee count at Microchips Biotech is 10.
Microchips Biotech develops microchip implants for drug delivery. Its platform technology is an implantable microchip that can be inserted in a physicians office under local anesthesia and can be activated or inactivated wirelessly. This microchip can then release preset doses of the device over months and years. Microchips has won a grant from the Bill and Melinda Gates Foundation to use its platform technology to develop an implantable contraceptive device for women with a life of 16 years. In addition, the company has a partnership with Teva to apply its drug delivery platform for Teva generics in the management of chronic diseases, like osteoporosis. Microchips was co-founded by MITs Robert Langer and Michael Cima. The technology can be used for therapies that require frequent, long-term dosing, or delivery via injection in diseases such as osteoporosis, diabetes, multiple sclerosis, pain management and several others.
Microchips Biotech's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
Microchips Biotech has 10 investors. Key investors include Medtronic, Novartis, Teva Pharmaceuticals, Daré Bioscience, and Polaris Partners.